“Advancements in recombinant DNA, cloning, and biomanufacturing have reduced our reliance on animals to serve as chemical factories while leading to more precise and efficient antibodies and antivenoms. We have now reached the point where just about any molecule that has historically been made from animals can be made synthetically from engineered cells. However, just because it is technically feasible to move completely away from biopharming does not mean that it will be easy. And while there has been progress in eschewing animal-derived products in some areas, such as with insulin, others, like synthetic antivenom or vaccine production, have been less straightforward. Solutions to these require not only mimicking what animal biology does naturally but doing so at scale.”

From Works in Progress.